Procept BioRobotics wins de novo nod from FDA for Aquabeam prostate treatment

The Robot Report

Procept BioRobotics said today that it won de novo clearance from the FDA for its Aquabeam device for treating benign prostate hyperplasia, saying it plans to have the device on the U.S. market early next year. Redwood Shores, Calif.-based Procept said the federal safety watchdog used the 181-patient Water study to inform its decision. The trial, comparing Aquablation…

The post Procept BioRobotics wins de novo nod from FDA for Aquabeam prostate treatment appeared first on The Robot Report.


Source: therobotreport

Please follow and like us:

Leave a Reply